Do lifestyle choices impact how fast results are seen
All potential participants provided written informed consent
L.HuangH
C s 2: S 7 ng 58 V Trng Phng, Thanh Xun Trung, Thanh Xun, H Ni a ch ti y C s 3: Chung c Ecogreen City, S 286 Nguyn Xin, Tn Triu, Thanh Tr, H Ni a ch ti y *C s Ha Bnh C s 1: S 201 Phng Hng, P Hu Ngh, Tp Ha Bnh (Gn ch Tn Thnh) a ch ti y C s 2: Ng Ba Xa, Xut Ha, Lc Sn, Ha Bnh (Hiu thuc L Th Hi) a ch ti y C s 3: Ph Lc Mi, TT V Bn, Lc Sn, Ha Bnh (Cng Bnh vin huyn Lc Sn) * Nu bnh nhn tm v mun mua cc loi thuc k n, thuc c tr kh tm hoc khi a ch nh xa cc bnh vin trn v cn mua thuc
Retatrutide led to dose-dependent reductions in body weight of up to 24.2% at 48 weeks, with a safety profile comparable to other GLP-1-based therapies. Jastreboff et al., NEJM Secondary Benefits Improved HbA1c in both diabetic and pre-diabetic participants Significant reductions in liver fat (a marker for NAFLD/NASH reversal) Lowered triglycerides, LDL, and inflammatory markers Favorable impact on blood pressure and fasting insulin levels Tolerability and Safety Most side effects were GI-related and dose-dependent : Nausea Constipation Occasional vomiting All were similar in frequency and severity to those seen in Semaglutide trials No serious adverse events were reported Dropout rates were low across all dose groups These results suggest Retatrutide may offer not only more dramatic weight loss , but also better metabolic improvements and potential muscle-sparing advantages making it a standout candidate for both medical and performance-focused applications
It can be jarring for some, but we believe that part of normalizing GLP-1s-as-healthcare starts with demystifying what the experience is really like
